The discovery and development of HMG-CoA reductase inhibitors.

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906

All ras proteins are polyisoprenylated but only some are palmitoylated

Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630

Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.

(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,426

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954

Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity

Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

Influence of nicotinic acid on serum cholesterol in man

Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 726

Receptor-Mediated Control of Cholesterol Metabolism: Study of human mutants has disclosed how cells regulate a substance that is both vital and lethal.

Brown, M. S., & Goldstein, J. L. (1976) · Science · doi:10.1126/science.174194 · Cited by 725

Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity

Brown, M. S., & Goldstein, J. L. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.788 · Cited by 601

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

Bilheimer, D. W., Grundy, S. M., Brown, M. S., & Goldstein, J. L. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.4124 · Cited by 557

Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase

Brown, M. S., Faust, J. R., Goldstein, J. L., Kaneko, I., & Endo, A. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38120-6 · Cited by 556

Genetic and Pharmacological Suppression of Oncogenic Mutations in RAS Genes of Yeast and Humans

Schafer, W. R., Kim, R., Sterne, R. E., Thorner, J. W., Kim, S., & Rine, J. (1989) · Science · doi:10.1126/science.2569235 · Cited by 530

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.

Kovanen, P. T., Bilheimer, D. W., Goldstein, J. L., Jaramillo, J. J., & Brown, M. S. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.1194 · Cited by 421

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

Tsujita, Y., Kuroda, M., Shimada, Y., Tanzawa, K., ARAI, M., Kaneko, I., Tanaka, M., Masuda, H., Tarumi, C., Watanabe, Y., et al. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90117-7 · Cited by 373

Regulation of Cholesterol Metabolism

Dietschy, J. M., & Wilson, J. D. (1970) · New England Journal of Medicine · doi:10.1056/nejm197005142822005 · Cited by 362

Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum

BROWN, A. G., Smale, T. C., King, T. J., Hasenkamp, R., & Thompson, R. H. (1976) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19760001165 · Cited by 360

Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor.

Habenicht, A. J. R., Glomset, J. A., & Ross, R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70760-1 · Cited by 349

Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Human Fibroblasts by Lipoproteins

Brown, M. S., Dana, S. E., & Goldstein, J. L. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.2162 · Cited by 344

Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate

THORP, J. M., & WARING, W. S. (1962) · Nature · doi:10.1038/194948a0 · Cited by 342

Regulation of Cholesterol Metabolism

Dietschy, J. M., & Wilson, J. D. (1970) · New England Journal of Medicine · doi:10.1056/nejm197005212822105 · Cited by 337

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.

Ma, P. T. S., Gil, G., Südhof, T. C., Bilheimer, D. W., Goldstein, J. L., & Brown, M. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8370 · Cited by 334

Feedback Control of Mevalonate Synthesis by Dietary Cholesterol

Siperstein, M. D., & Fagan, V. M. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96879-1 · Cited by 332

Reduction of Blood Cholesterol in Man

POLLAK, O. J. (1953) · Circulation · doi:10.1161/01.cir.7.5.702 · Cited by 327

Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum.

Liscum, L., Finer-Moore, J. S., Stroud, R. M., Luskey, K. L., Brown, M. S., & Goldstein, J. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89764-2 · Cited by 308

Effect of cholesterol feeding and fasting on sterol synthesis in seventeen tissues of the rat

Dietschy, J. M., & Siperstein, M. D. (1967) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38921-5 · Cited by 296

Essential role for mevalonate synthesis in DNA replication

Quesney-Huneeus, V., Wiley, M. H., & Siperstein, M. D. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5056 · Cited by 293

Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase

Endo, A. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00382a001 · Cited by 285

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolin

Hoffman, W. F., Alberts, A. W., Anderson, P., Chen, J. S., Smith, R. L., & Willard, A. K. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00155a040 · Cited by 268

Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase

Endo, A., Tsujita, Y., KURODA, M., & Tanzawa, K. (1977) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1977.tb11637.x · Cited by 263

Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia

Mabuchi, H., Haba, T., Tatami, R., Miyamoto, S., Sakai, Y., Wakasugi, T., Watanabe, A., Koizumi, J., & Takeda, R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050902 · Cited by 262

Abortions because of unavailability of prenatal diagnosis.

Hook, E. B., & Am, W. (1981) · PubMed · Cited by 261

Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum

Chin, D. J., Gil, G., Russell, D. W., Liscum, L., Luskey, K. L., Basu, S. K., Okayama, H., Berg, P. R., Goldstein, J. L., & Brown, M. S. (1984) · Nature · doi:10.1038/308613a0 · Cited by 257

Evidence for modification of lamin B by a product of mevalonic acid.

Wolda, S. L., & Glomset, J. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68736-8 · Cited by 254

Inhibitory Effects on Lipid Metabolismn in Cultured Cells of ML‐236B, a Potent Inhibitor of 3‐Hydroxt‐3‐methylglutaryl‐Cornzyme‐A Reductase

KANEKO, O., Yoko, H.-S., & Endo, A. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12380.x · Cited by 249

Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Chin, D. J., Luskey, K. L., Anderson, R. G. W., Faust, J. R., Goldstein, J. L., & Brown, M. S. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1185 · Cited by 249

Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins.

Schmidt, R., Schneider, C. J., & Glomset, J. A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90945-2 · Cited by 235

Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Endo, A. (1980) · The Journal of Antibiotics · doi:10.7164/antibiotics.33.334 · Cited by 233

Therapeutic effects of ML-236B in primary hypercholesterolemia

Yamamoto, A., Sudo, H., & Endo, A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90124-0 · Cited by 231

Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial Hypercholesterolemia

Hunninghake, D. B., Larose, J., Palmer, R. H., & Leon, A. S. (1986) · JAMA · doi:10.1001/jama.256.20.2829 · Cited by 231

Regulation of Cholesterol Biosynthesis in Normal and Malignant Tissues

(1970) · Current topics in cellular regulation · doi:10.1016/b978-0-12-152802-7.50009-8 · Cited by 227

Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control

Dietschy, J. M., & Wilson, J. D. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105706 · Cited by 223

Simvastatin

Todd, P. A., & Goa, K. L. (1990) · Drugs · doi:10.2165/00003495-199040040-00007 · Cited by 221

Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals

Endo, A., Tsujita, Y., Masao, K., & Tanzawa, K. (1979) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(79)90028-6 · Cited by 216

Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia

Havel, R. J., HUNNINGHAKE, D. B., ILLINGWORTH, D. R., Lees, R. S., STEIN, E. A., TOBERT, J. A., BACON, S. R., BOLOGNESE, J. A., FROST, P. H., LAMKIN, G. E., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-5-609 · Cited by 212

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.

Grundy, S. M., & Vega, G. L. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34252-8 · Cited by 208

Prevention of Cyclic and Triton-induced Increases in Hydroxymethylglutaryl Coenzyme A Reductase and Sterol Synthesis by Puromycin

Kandutsch, A. A., & Saucier, S. E. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78226-x · Cited by 206

The ras oncogene--an important regulatory element in lower eucaryotic organisms

Gibbs, W. W., & Marshall, M. S. (1989) · Microbiological Reviews · doi:10.1128/mr.53.2.171-185.1989 · Cited by 205

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

Tobert, J. A., Bell, G. D., Birtwell, J., James, I. M., Kukovetz, W. R., Pryor, J., Buntinx, A., Holmes, I. B., Chao, Y. S., & Bolognese, J. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110530 · Cited by 204

Cholesterol Biosynthesis in Preparations of Liver from Normal, Fasting, X-irradiated, Cholesterol-fed, Triton, or Δ4-Cholesten-3-one-treated Rats

Bucher, N. L. R., McGarrahan, K., Gould, E., & Loud, A. V. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70285-8 · Cited by 199

Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia

Mabuchi, H., Sakai, T., Sakai, Y., Yoshimura, A., Watanabe, A., WAKASUGI, T., Koizumi, J., & Takeda, R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303173081101 · Cited by 198

HMG CoA reductase inhibitors

Hunninghake, D. B. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199202000-00005 · Cited by 196

Amplification of the gene for 3-hydroxy-3-methylglutaryl coenzyme A reductase, but not for the 53-kDa protein, in UT-1 cells.

Luskey, K. L., Faust, J. R., Chin, D. J., Brown, M. S., & Goldstein, J. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82087-0 · Cited by 195

Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe.

Liscum, L., Luskey, K. L., Chin, D. J., Ho, Y. K., Goldstein, J. L., & Brown, M. S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82085-7 · Cited by 195

Improved assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase

Goldfarb, S., & Pitot, H. C. (1971) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39504-3 · Cited by 176

Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovary cell nuclei.

Beck, L. A., Hosick, T. J., & Sinensky, M. S. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.4.1307 · Cited by 175

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

Illingworth, D. R., & Sexton, G. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111618 · Cited by 170

Plasma mevalonate as a measure of cholesterol synthesis in man.

Parker, T. S., McNamara, D. J., Brown, C. D., Kolb, R., AHRENS, E. H., Alberts, A. W., Tobert, J. A., Chen, J., & Schepper, P. J. D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111495 · Cited by 167

Therapeutic response to lovasatain (Mevinolin) in nonfamilial hypercholesterolemia - A Multicenter study

Hunninghake, D. B., Larose, J., Palmer, R. H., & Leon, A. S. (1986) · JAMA · Cited by 166

Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes Mellitus

Garg, A., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180204 · Cited by 158

Plasma cholesterol lowering action of bile acid binding polymers in experimental animals

Tennent, D. M., Siegel, H., Zanetti, M. E., Kuron, G. W., Ott, W., & Wolf, F. J. (1960) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41235-0 · Cited by 157

EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA

Mol, M. J. T. M., Leuven, J. A. G., Erkelens, D. W., Schouten, T. A., & Stalenhoef, A. F. H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90598-2 · Cited by 156

Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme a reductase and evidence for regulation of its mRNA.

Chin, D. J., Luskey, K. L., Faust, J. R., MacDonald, R. J., Brown, M. S., & Goldstein, J. L. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7704 · Cited by 144

Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia

Illingworth, D. R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-5-598 · Cited by 129

Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism

Vega, G. L., & Grundy, S. M. (1988) · Kidney International · doi:10.1038/ki.1988.125 · Cited by 128

Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.

Grundy, S. M., & Bilheimer, D. W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2538 · Cited by 123

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins

Vega, G. L., Krauss, R. M., & Grundy, S. M. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00124.x · Cited by 120

Combination Drug Therapy for Familial Combined Hyperlipidemia

East, C. A., Bilheimer, D. W., & Grundy, S. M. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-1-25 · Cited by 118

Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase

Tsujita, Y., Kuroda, M., Tanzawa, K., KITANO, N., & Endo, A. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90174-6 · Cited by 112

Influence of Combined Therapy with Mevinolin and Interruption of Bile-Acid Reabsorption on Low Density Lipoproteins in Heterozygous Familial Hypercholesterolemia

Grundy, S. M., Vega, G. L., & Bilheimer, D. W. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-339 · Cited by 106

Mode of interaction of .beta.-hydroxy-.beta.-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds

Nakamura, C. E., & Abeles, R. H. (1985) · Biochemistry · doi:10.1021/bi00327a014 · Cited by 105

Lipoprotein receptors, cholesterol metabolism, and atherosclerosis.

Goldstein, J., & Brown, M. S. (1975) · PubMed · Cited by 105

Cataracts in Patients Treated with Triparanol

Laughlin, R. C. (1962) · JAMA · doi:10.1001/jama.1962.03050300059020a · Cited by 100

Citrinin, an inhibitor of cholesterol synthesis.

Endo, A., & KURODA, M. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.841 · Cited by 99

Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemia

Kuroda, M., Tanzawa, K., Tsujita, Y., & Endo, A. (1977) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(77)90238-7 · Cited by 88

Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover

Uauy, R. D., Vega, G. L., Grundy, S. M., & Bilheimer, D. W. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80289-0 · Cited by 86

Lovastatin therapy in familial dysbetalipoproteinemia: Effects on kinetics of apolipoprotein B

Vega, G. L., East, C. A., & Grundy, S. M. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90107-4 · Cited by 82

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia

Hoeg, J. M., Maher, M. B., Zech, L. A., Bailey, K. R., Gregg, R. E., Lackner, K. J., Fojo, S. S., Anchors, M., Bojanovski, M., Sprecher, D. L., et al. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90733-2 · Cited by 82

The Effect of CS-514 on Serum Lipids and Apolipoproteins in Hypercholesterolemic Subjects

Nakaya, N. (1987) · JAMA · doi:10.1001/jama.1987.03390220086026 · Cited by 81

Hypolipidemic effects in monkeys of ML‐236B, a competitive inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase

Kuroda, M., Tsujita, Y., Tanzawa, K., & Endo, A. (1979) · Lipids · doi:10.1007/bf02533537 · Cited by 81

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia

Hunninghake, D. B., Knopp, R. H., Schonfeld, G., Goldberg, A. C., Brown, W. V., Schaefer, E. J., Margolis, S., Dobs, A. S., Mellies, M. J., Insull, W., et al. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90185-l · Cited by 77

THE INFLUENCE OF INTRAVENOUSLY ADMINISTERED SURFACE-ACTIVE AGENTS ON THE DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS

Kellner, A., Correll, J. W., & Ladd, A. T. (1951) · The Journal of Experimental Medicine · doi:10.1084/jem.93.4.385 · Cited by 71

Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids

Beck, G., Keßeler, K., Baader, E., Bartmann, W., Bergmann, A., Granzer, E., Jendralla, H., Kerékjártó, B. V., & Krause, R. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00163a010 · Cited by 68

A study of the Influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells.

Schmidt, R., Glomset, J. A., Wight, T. N., Habenicht, A. J. R., & Ross, R. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.95.1.144 · Cited by 68

Regulation of Hmg-coa Reductase

(1985) · Elsevier eBooks · doi:10.1016/b978-0-12-564430-3.x5001-4 · Cited by 65

Lowering of Serum Lipid Concentrations

Goldsmith, G. A. (1960) · A M A Archives of Internal Medicine · doi:10.1001/archinte.1960.00270160010003 · Cited by 65

The Biosynthesis of Mevalonic Acid from 1-C14-Acetate by a Rat Liver Enzyme System

Knauss, H. J., Porter, J. W., & Wasson, G. W. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69680-2 · Cited by 62

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia

Illingworth, D. R., & Bacon, S. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90589-3 · Cited by 62

Kinetic Analysis of the Reaction Catalyzed by Rat‐Liver 3‐Hydroxy‐3‐methylglutaryl‐coenzyme‐A Reductase Using Two Specific Inhibitors

Tanzawa, K., & Akira, E. N. D. O. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb13177.x · Cited by 61

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

Yuan, J., Tsai, M. Y., Hegland, J., & Hunninghake, D. B. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90017-w · Cited by 60

Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia

Mabuchi, H., KAMON, N., Fujita, H., Michishita, I., TAKEDA, M., Kajinami, K., Itoh, H., WAKASUGI, T., & Takeda, R. (1987) · Metabolism · doi:10.1016/0026-0495(87)90046-1 · Cited by 53

Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia

Illingworth, D. R. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.185 · Cited by 51

Preliminary report: Treatment of type 3 hyperlipoproteinemia with mevinolin

East, C. A., Grundy, S. M., & Bilheimer, D. W. (1986) · Metabolism · doi:10.1016/0026-0495(86)90106-x · Cited by 51

Reduction of Serum Cholesterol by Sodium Dextro-Thyroxine

Starr, P. (1960) · Archives of Internal Medicine · doi:10.1001/archinte.1960.00270180008002 · Cited by 51

Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II)

Pietro, D. A., Alexander, S., Mantell, G., Staggers, J. E., & Cook, T. J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90251-8 · Cited by 47

A role for isoprenoid lipids in the localization and function of an oncoprotein.

Rine, J., & Sh, K. (1990) · PubMed · Cited by 38

SYNVINOLIN IN HYPERCHOLESTEROLAEMIA

Olsson, A., Mölgaard, J., & Schenk, H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90070-x · Cited by 37

The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia

HOOGERBRUGGE, N., Mj, M., van Dormaal, J. J., Rustemeijer, C., Muls, E., Stalenhoef, A. F. H., & Birkenhäger, J. C. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00229.x · Cited by 36

Mevalonolactone derivatives as inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Sato, A., Noguchi, H., Mitsui, S., Kaneko, I., & SHIMADA, Y. (1980) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.28.1509 · Cited by 34

The prenylation of proteins

Glomset, J., Gelb, M. H., & Farnsworth, C. C. (1991) · Current Opinion in Lipidology · doi:10.1097/00041433-199104000-00010 · Cited by 33

Safety, Tolerability, and Efficacy of Simvastatin and Fenofibrate - A Multicenter Study

Ziegler, O., & Drouin, P. (2008) · Cardiology · doi:10.1159/000174683 · Cited by 29

Time-dependent, irreversible inhibition of 3-hydroxy-3-methylglutaryl-coenzyme a reductase by the antibiotic citrinin

Tanzawa, K., Masao, K., & Endo, A. (1977) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(77)90126-6 · Cited by 23

Microbial hydroxylation of compactin (ML-236B) and monacolin K.

Yamashita, H., TSUBOKAWA, S., & Endo, A. (1985) · The Journal of Antibiotics · doi:10.7164/antibiotics.38.605 · Cited by 23

Triton hypercholesteremia: cause or consequence of augmented cholesterol synthesis

BYERS, S. O., Friedman, M., & Sugiyama, T. (1963) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1963.204.6.1100 · Cited by 23

Improvement in the Regulation of Cellular Cholesterologenesis in Diabetes: the Effect of Reduction in Serum Cholesterol by Simvastatin

Owens, D., Stinson, J. C., Collins, P. B., Johnson, A., & TOMKIN, G. H. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01562.x · Cited by 18

SPECIFIC INHIBITION OF DESMOSTEROL SYNTHESIS BY ML-236B IN MOUSE LM CELLS GROWN IN SUSPENSION IN A LIPID-FREE MEDIUM

Doi, O., & Endo, A. (1978) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.31.225 · Cited by 17

Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.

Yamamoto, A., Yamamura, T., Yokoyama, S., Sudo, H., & Matsuzawa, Y. (1984) · PubMed · Cited by 15

Specific Nonsterol Inhibitors of HMG-CoA Reductase

Endo, A. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-564430-3.50006-2 · Cited by 13

Two Japanese Kindreds of Familial Hypercholesterolemia Including Homozygous Cases. A Report of Cases, and Studies on Serum-Lipoproteins and Enzymes

Yamamoto, A., Endo, A., Kitano, Y., Okada, A., ISHIKAWA, K., Kuroshima, T., & Kaneko, I. (1978) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.17.230 · Cited by 11

The effects of an inhibitor of cholesterol biosynthesis triparanol (MER-29), in subjects with and without coronary artery disease.

Hollander, W., & Chobanian, A. V. (1959) · PubMed · Cited by 9

Nutrition and therapeutics

Nestel, P. J., & Eisenberg, S. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199202000-00001 · Cited by 2

Nutrition and therapeutics: Editorial Overview

Nestel, P. J., & Grundy, S. M. (1990) · Current Opinion in Lipidology · doi:10.1097/00041433-199002000-00002 · Cited by 1

Triglycerides and cardiovascular disease

Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419

The role of natural product chemistry in drug discovery

Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116

Natural products to drugs: natural product-derived compounds in clinical trials

Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,086

A Tale of Coronary Artery Disease and Myocardial Infarction

Nabel, E. G., & Braunwald, E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112570 · Cited by 1,024

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 896

HMG-CoA reductase inhibitors as potent cholesterol lowering drugs

Tsujita, Y. (1994) · Gordon and Breach Science Publishers eBooks · Cited by 2

Lipid-lowering drugs: discovery and development of HMG-CoA reductase inhibitors.

Tsujita, Y. (1995) · 生体の科学

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

The discovery of the HMG-CoA reductase inhibitors “statins”: A historical perspective

Endo, A. (2001) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.28.6_111